Health care startups in Minhang, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tianhu Technology | Minhang | Series A | $29.0M | 2026-07-13 |
| YolTech Therapeutics | Minhang | Series C | $73.8M | 2026-05-29 |
| Tushen Zhihe | Minhang | Seed | $1.4M | 2026-11-09 |
| Kai Medtech | Minhang | Series D | $73.9M | 2026-07-28 |
| Pinnacles Medical | Minhang | Series A | $46.9M | 2021-10-21 |
| Rigen Biotech | Minhang | Series B | $14.1M | 2025-11-28 |
6 rows of the CSV in 5 of its 18 columns.
- The 61 health care startups in Minhang, China have raised $826.5M in total.
- 16 of them closed their most recent round in the last 12 months, $279.0M combined.
- The largest of those rounds is Kai Medtech's $73.9M Series D, dated July 2026.
- The most recent is Tushen Zhihe's $1.4M seed round on 9 November 2026.
- Wuxi Capital is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 30 companies (49%).
- 34% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (43% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 61| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital, CHENGMEI VENTURES | 11 to 50 | 2023 |
| Kai Medtech | Kai Medtech markets and sells vascular intervention medical devices. | Health care | Series D | $73.9M | 2026-07-28 | $105.3M | Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 | 51 to 100 | 2019 |
| Tianhu Technology | Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. | Artificial intelligence | Series A | $29.0M | 2026-07-13 | $54.2M | Qiming Venture Partners, GSR United Capital, 3E Bioventures | 11 to 50 | 2021 |
| YolTech Therapeutics | YolTech Therapeutics combines LNP delivery with gene editing technology for biotechnology applications. | Biotech | Series C | $73.8M | 2026-05-29 | $144.9M | K2VC, UnityVC, Decheng Capital +1 | 11 to 50 | 2021 |
| Rigen Biotech | Rigen Biotech provides molecular diagnosis of thyroid tumors. | Biotech | Series B | $14.1M | 2025-11-28 | $29.8M | BioTrack Capital, Boyuan Capital, Guotai Junan Innovation Investment +1 | 101 to 250 | 2017 |
| Umai Technology | Umai Technology manages skin images, processes them, and supports clinical diagnosis with software. | Health care | Series A | $10.0M | 2021-11-05 | Matrix Partners China, Cenova | 2015 | ||
| Pinnacles Medical | Pinnacles Medical is an AI company that researches and develops diagnostic solutions for medical needs. | Artificial intelligence | Series A | $46.9M | 2021-10-21 | $46.9M | Vertex Ventures China | 2020 | |
| Yi Kang Zhimian | Yi Kang Zhimian offers health information services through an online cloud-based platform. | Health care | Series A | $1.5M | 2016-05-06 | Grand Yangtze Capital | 11 to 50 | 2015 |
Table 1. Health care startups in Minhang, China: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 61.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kai Medtech | Kai Medtech markets and sells vascular intervention medical devices. | Health care | Series D | $73.9M | 2026-07-28 | $105.3M | Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 | 51 to 100 | 2019 |
| 2 | YolTech Therapeutics | YolTech Therapeutics combines LNP delivery with gene editing technology for biotechnology applications. | Biotech | Series C | $73.8M | 2026-05-29 | $144.9M | K2VC, UnityVC, Decheng Capital +1 | 11 to 50 | 2021 |
| 3 | Tianhu Technology | Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. | Artificial intelligence | Series A | $29.0M | 2026-07-13 | $54.2M | Qiming Venture Partners, GSR United Capital, 3E Bioventures | 11 to 50 | 2021 |
| 4 | Rigen Biotech | Rigen Biotech provides molecular diagnosis of thyroid tumors. | Biotech | Series B | $14.1M | 2025-11-28 | $29.8M | BioTrack Capital, Boyuan Capital, Guotai Junan Innovation Investment +1 | 101 to 250 | 2017 |
| 5 | Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital, CHENGMEI VENTURES | 11 to 50 | 2023 |
Table 2. Health care startups in Minhang, China: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Wuxi Capital | Angel group | Wuxi Shi, China | 2 | 3% | 2 | Tushen Zhihe, Kai Medtech |
| 2 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Tianhu Technology |
| 3 | GSR United Capital | Venture capital firm | Beijing, China | 1 | 2% | 1 | Tianhu Technology |
| 4 | 3E Bioventures | Venture capital firm | Beijing, China | 1 | 2% | 1 | Tianhu Technology |
| 5 | Decheng Capital | Venture capital firm | Menlo Park, United States | 1 | 2% | 1 | YolTech Therapeutics |
| 6 | K2VC | Angel group | Beijing, China | 1 | 2% | 1 | YolTech Therapeutics |
| 7 | UnityVC | Angel group | Beijing, China | 1 | 2% | 1 | YolTech Therapeutics |
| 8 | Grand Flight Investment | Private equity firm | Shanghai, China | 1 | 2% | 1 | YolTech Therapeutics |
| 9 | CHENGMEI VENTURES | Venture capital firm | Beijing, China | 1 | 2% | 1 | Tushen Zhihe |
| 10 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 1 | 2% | 1 | Kai Medtech |
| 11 | Guoxin Investment | Corporate venture arm | Shanghai, China | 1 | 2% | 1 | Kai Medtech |
| 12 | Hengxu Capital | Private equity firm | Jiading, China | 1 | 2% | 1 | Kai Medtech |
| 13 | Vertex Ventures China | Venture capital firm | Beijing, China | 1 | 2% | ||
| 14 | Boyuan Capital | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Rigen Biotech |
| 15 | Guotai Junan Innovation Investment | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Rigen Biotech |
Table 3. Health care startups in Minhang, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 30 | 49% | $597.5M |
| Software | 8 | 13% | $102.7M |
| Artificial intelligence | 5 | 8% | $102.7M |
| Hardware | 2 | 3% | |
| Energy | 1 | 2% | $54.2M |
| Fintech | 1 | 2% | $1.5M |
Table 4. Health care startups in Minhang, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 23 | 38% | $770K |
| Series A | 17 | 28% | $10.0M |
| Series B | 11 | 18% | $14.4M |
| Series C | 6 | 10% | $72.6M |
| Series D+ | 4 | 7% | $38.7M |
Table 5. Health care startups in Minhang, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 6% | $1.4M |
| July 2026 | 4 | 25% | $102.9M |
| May 2026 | 3 | 19% | $73.8M |
| April 2026 | 3 | 19% | $72.6M |
| February 2026 | 1 | 6% | |
| December 2025 | 1 | 6% | |
| November 2025 | 3 | 19% | $28.3M |
Table 6. Health care startups in Minhang, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 12 | 20% | $250.7M |
| 2025 | 8 | 13% | $29.7M |
| 2024 | 3 | 5% | $27.6M |
| 2023 | 7 | 11% | $47.4M |
| 2022 | 6 | 10% | $194.4M |
| 2021 | 4 | 7% | $105.6M |
Table 7. Health care startups in Minhang, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 8 | 14% |
| 2020 to 2022 | 12 | 20% |
| 2015 to 2019 | 20 | 34% |
| 2010 to 2014 | 12 | 20% |
| Before 2010 | 7 | 12% |
Table 8. Health care startups in Minhang, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 9% |
| 11 to 50 | 20 | 43% |
| 51 to 100 | 11 | 23% |
| 101 to 250 | 7 | 15% |
| 251 to 500 | 2 | 4% |
| 501 to 1,000 | 2 | 4% |
| 1,001 to 5,000 | 1 | 2% |
Table 9. Health care startups in Minhang, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Minhang, China. On 16 November 2026 that is 61 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 61 rows: 21 have no round amount, 0 no city and 24 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Minhang, China are on the list?
- 61, in the file dated 16 November 2026. 16 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 61 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.